|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Immunotherapy and therapeutic vaccines in prostate cancer: an update on current strategies and clinical implications显示文摘在最近的年里,免疫疗法为前列腺癌症的治疗作为可行、吸引人的策略出现了。当有指向免疫系统的多重方法时,治疗学的癌症疫苗和有免疫力的检查点禁止者在迟了阶段的临床的试用是很成功的。为无征状或最低限度地征兆的变形前列腺癌症的 sipuleucel-T 的里程碑食物药品管理局赞同与癌症疫苗 PSA 得信佳和有免疫力的检查点禁止者 ipilimumab 为进行中的阶段 III 试用作准备。没有短期的变化,这些基于免疫者的治疗的一个普通特征是改进全面幸存的外观。这类效果看起来由于肿瘤生长率动力学,激活的免疫系统在施加减缓网络肿瘤生长的经常的 immunologic 压力的调整。新兴的数据建议为癌症疫苗的临床的试用的理想的人口是有更低的肿瘤体积和更少的好攻击的疾病的病人。把免疫疗法与标准治疗相结合的联合策略被显示了扩充有免疫力的反应和临床的利益。 | B Harpreet Singh James L Gulley | 2014 | Asian Journal of Andrology2014，16，3： | 6 |
| 2 | Perspectives on the clinical development of mmunotherapy in prostate cancer显示文摘 | Lisa M Cordes James L Gulley Ravi A Madan | 2018 | Asian Journal of Andrology2018，20，3： | 2 |
| 3 | Laboratory Assays for Epstein-Barr Virus-Related Disease 显示文摘 | Margaret L Gulley Weihua Tang | 2008 | JMD2008，4，： | 1 |
| 4 | Infec tious Bronchitis Virus In The Chicken Harderian Gland and Lachrymal Fluid: Viral Load, Infectivity, Immune Cell Re- sponses, and Effects of Viral Immunodeficiency显示文摘 | Van Ginkel F W Van Santen V L Gulley S L | 2008 | Summa rized from Avian Diseases2008，52，60： | 1 |
| 5 | Recommend- ed principles and practices for validating clinical molecu- lar pathology tests显示文摘 | Jennings L Van Deerlin VM Gulley ML | 2009 | Arch Pathol Lab Med2009，133，： | 1 |
| 6 | Highlights on FOXO3 and tumor-associated dendritic :ells in prostate cancer显示文摘 | Kwong Y Tsang James L Gulley | 2011 | Asian Journal of Andrology2011，13，5： | 1 |
| 7 | Final analysis of a phase II trial using sorafenib for metastatic castration-resistant prostate cancer显示文摘 | Aragon-Ching JB Jain L Gulley JL | 2009 | BJU Int2009，103，12： | 1 |
| 8 | Conjuncti- va-associated lymphoid tissue in avian mucosal immunity显示文摘 | Van Ginkel F W Gulley S L Lammers A | 2012 | Devel Comp Immunol2012，36，2： | 1 |
| 9 | Phase I study of sequential vaccinations with fowlpox-CEA (6D)-TRICOM alone and sequentially with vaccinia- CEA(6D)-TRICOM, with and without granulocytemacrophage colony-stimulating factor, in patients with carcinoembryonic antigen-expressing carcinomas 显示文摘 | Marshall J L Gulley J L Arlen P M | 2005 | J Clin Oncol2005，23，： | 1 |
| 10 | Final analysis of a phase Ⅱ trial using sorafenib for metastatic castration-resistant prostate cancer显示文摘 | ARAGON-CHING J B JAIN L GULLEY JL | 2009 | BJU Int2009，103，： | 1 |
| 11 | Differential signaling pathways are activated in the Epstein- Barr virus-associated malignancies nasopharyngeal carcinoma and Hodgkin lymphoma显示文摘 | Morrison J A Gulley M L Pathmanathan R | 2004 | Cancer Res2004，64，15： | 1 |
| 12 | Phase I study of sequential vaccinations with Flowpox-CEA-tricom alone and sequentially with vaccinia-CEA-tricom, with and without granulocyte-macrophage colon-stimulating factor in patients with carcinoembryonic antigen expressing carcinomas显示文摘 | John L Marshall James L Gulley | 2005 | J Clinical Oncology2005，23，4： | 1 |
| 13 | Combining a recombinant cancer vaccine with standard definitive radiotherapy in patients with localized prostate cancer显示文摘 | James L Gulley L Philip M | 2005 | Clin Cancer Res2005，11，9： | 1 |
| 14 | Structures ofan electrorheological fluid显示文摘 | Gulley G L Tao R | 1997 | PhysRev E1997，56，4： | 1 |
| 15 | Induction of mucosal immunity in the avian Harderian gland with a replication-deficient Ad5 vector expressing avian influenza H5 hemagglutinin 显示文摘 | Van ginkel F W Tang D C Gulley S L | 2009 | Dev Comp Immunol2009，33，1： | 1 |
| 16 | Recommended principles and practices for validating clinical molecular pathology tests显示文摘 | Jennings L Van Deerlin VM Gulley ML | 2009 | ArchPathol Lab Med2009，133，： | 1 |
| 17 | Guidelines for interpreting EBER in situ hybridization and LMP1 immu- nohistochemical tests for detecting Epstein-Barr virus in Hodgkin lymphoma显示文摘 | GULLEY M L GLASER S L CRAIG F E | 2002 | Am J Clin Pathol2002，117，2： | 1 |
| 18 | Molecular diagnosis of Epstein-Barr virus-related dis-eases显示文摘 | Gulley M L | 2001 | J Mol Diagn2001，3，1： | 1 |
| 19 | A randomized phase IIstudy of concurrent docetaxel plus vaccine versus vaccine alone inmetastatic androgen-independent prostate cancer 显示文摘 | Arlen P M Gulley J L Parker C | 2010 | ClinCancer2010，12，： | 1 |
| 20 | PANVAC-VF: poxvi- ral-based vaccine therapy targeting CEA and MUC1 in carcinoma显示文摘 | Madan R A Arlen P M Gulley J L | 2007 | Expert Opin Biol Ther2007，7，4： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员